Aaron Schuchart - Net Worth and Insider Trading
Aaron Schuchart Net Worth
The estimated net worth of Aaron Schuchart is at least $2,843 dollars as of 2024-12-01. Aaron Schuchart is the Chief Business Officer of Spyre Therapeutics Inc and owns about 100 shares of Spyre Therapeutics Inc (SYRE) stock worth over $2,843. Details can be seen in Aaron Schuchart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aaron Schuchart has not made any transactions after 2018-09-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aaron Schuchart
Aaron Schuchart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aaron Schuchart owns 2 companies in total, including Spyre Therapeutics Inc (SYRE) , and Lumos Pharma Inc (LUMO) .
Click here to see the complete history of Aaron Schuchart’s form 4 insider trades.
Insider Ownership Summary of Aaron Schuchart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2018-09-27 | Chief Business Officer |
| LUMO | Lumos Pharma Inc | 2021-05-19 | Chief Business Officer |
Aaron Schuchart Latest Holdings Summary
Aaron Schuchart currently owns a total of 1 stock. Aaron Schuchart owns 100 shares of Spyre Therapeutics Inc (SYRE) as of September 27, 2018, with a value of $2,843.
Latest Holdings of Aaron Schuchart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2018-09-27 | 100 | 28.43 | 2,843 |
Holding Weightings of Aaron Schuchart
Aaron Schuchart Form 4 Trading Tracker
According to the SEC Form 4 filings, Aaron Schuchart has made a total of 0 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years. The most-recent trade in Spyre Therapeutics Inc is the sale of 240 shares on September 27, 2018, which brought Aaron Schuchart around $57,000.
Insider Trading History of Aaron Schuchart
- 1
Aaron Schuchart Trading Performance
Aaron Schuchart Ownership Network
Aaron Schuchart Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Aaron Schuchart is the Chief Business Officer of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
Over the past 18 months, Aaron Schuchart made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .
In summary, during the past 3 months, insiders sold 25,531 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 25,531 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
Aaron Schuchart Mailing Address
Above is the net worth, insider trading, and ownership report for Aaron Schuchart. You might contact Aaron Schuchart via mailing address: C/o Aeglea Biotherapeutics, Inc., 901 S.mopac Expwy,bartonoaksplazone,#250, Austin Tx 78746.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
